BioSpace News Archive

DNAstack introduced a Beacon for SARS-CoV-2, commonly known as COVID-19, available at covid-19.dnastack.com.

As announced on March 16, 2020, RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, filed a Notification of Late Filing on Form 12b-25, indicating that the filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (the “Form 10-K”) would be delayed pending completion of an internal investigation of current and prior periods relating to the Company’s revenue recognition practices involving

Kane Biotech Inc. will announce its fourth quarter and full year 2019 financial results after market close on Thursday, March 26, 2020.

BiomX Inc . originally planned to be presented at the Annual Meeting of the American Academy of Dermatology (AAD) on March 20, 2020 before the conference was canceled due to ongoing COVID-19 pandemic concerns. The pre-clinical data

On March 18 and March 19, 2020 respectively, the European Commission and the U.S. Federal Trade Commission cleared the proposed acquisition of select Danaher businesses by Sartorius. Both approvals are an important milestone for the transaction originally announced in October 2019 , the completion of which is still subject

With cases of coronavirus COVID-19 disease rising at an unprecedented rate, CTK has taken their proven strength in developing infectious disease diagnostics and in collaboration with its partners in China , has proudly launched two diagnostic tests for this virus, both a real time PCR based nucleic acid detection kit and a serologic

In Partnership with Alto Pharmacy, Kits Will Provide Guidance to More Patients and Lessen Strain on Overburdened Clinics

Firetinas, invented by a group of scholars from Cambridge University and Manchester University, had successfully helped China to control corona virus.

CareDx, Inc. announces that the American Journal of Transplantation published a case report from Johns Hopkins on a successful kidney retransplantation in a patient who experienced rejection of a first kidney transplant after undergoing immune-stimulating therapy for the treatment of metastatic cutaneous squamous cell carcinoma.